Patent · US Active

Inhibitors of glutaminyl cyclase

US9656991B2 · kind B2 · utility

0Cited by
5References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 18, 2008
Grant dateMay 23, 2017
Priority date
Expiry dateJan 17, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I), combinations and uses thereof for disease therapy,or a pharmaceutically acceptable salt, solvate or polymorph thereof, including all tautomers and stereoisomers thereof wherein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.